First Detection of CTX-M-1, CMY-2, and QnrB19 Resistance Mechanisms in Fecal Escherichia coli Isolates from Healthy Pets in Tunisia

Vector-Borne and Zoonotic Diseases

Volumn 13, Issue 2, 2013, Pages 98-102

  Sallem, Rym Ben ^a   Gharsa, Haythem ^a   Slama, Karim Ben ^a   Rojo Bezares, Beatriz ^b   Estepa, Vanesa ^b   Porres Osante, Nerea ^b   Jouini, Ahlem ^a   Klibi, Naouel ^a   Sáenz, Yolanda ^b   Boudabous, Abdellatif ^a   Torres, Carmen ^b  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b UNIVERSITY OF LA RIOJA   (Spain)

Author keywords

CMY 2; CTX M 1; ESBL; Escherichia coli; fecal carriage; healthy pets; qnrB; Tunisia

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M 1; BETA LACTAMASE QNRB19; BETA LACTAMASE TEM 135; BETA LACTAMASE TEM 1B; BETA LACTAMASE TEM 1C; CEFOTAXIME; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CAT; DOG; ESCHERICHIA COLI; FECES ANALYSIS; INTEGRON; NONHUMAN; PRIORITY JOURNAL; TUNISIA;

ANIMALS; BETA-LACTAMASES; CATS; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FECES; GENE EXPRESSION REGULATION, BACTERIAL; PETS; TUNISIA;

EID: 84873363787     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2012.1047     Document Type: Article

References (40)

1. Ben Sallem, R, Ben Slama K, Estepa V, Jouini A, et al. Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 2012; 31:1511-1516.
2. Ben Slama K, Jouini A, Ben Sallem R, Somalo S, et al. Prevalence of broad-spectrum cephalosporin-resistant Escherichia coli isolates in food samples in Tunisia, and characterization of integrons and antimicrobial resistance mechanisms implicated. Int J Food Microbiol 2010; 137:281-286.
3. Ben Slama K, Ben Sallem R, Jouini A, Rachid S, et al. Diversity of genetic lineages among CTX-M-15 and CTX-M-14 producing Escherichia coli strains in a Tunisian hospital. Curr Microbiol 2011; 62:1794-1801.
4. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum b-lactamases in Lugo (Spain): Dissemination of clone O25b:H4-ST131 producing CTX-M-15.
5. Bouchakour M, Zerouali K, Gros Claude JD, Amarouch H, et al. Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing Enterobacteriaceae in Morocco. J Infect Dev Ctries 2010; 4:779-803.
6. Brin as L, Moreno MA, Teshager T, Saenz Y, et al. Monitoring and characterization of extended-spectrum beta-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003. Antimicrob Agents Chemother 2005; 49: 1262-1264.
7. Carattoli A, Lovari S, Franco A, Cordaro G, et al. Extendedspectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 2005; 49: 833-835.
8. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66:4555-4558.
9. Clermont O, Lavollay M, Vimont S, Deschamps C, et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 2008; 61:1024-1028.
10. CLSI. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. CLSI document M100-S20.Wayne Pennsylvania: CLSI, 2010.
11. Costa D, Poeta P, Brin as L, Saenz Y, et al. Detection of CTX-M-1 and TEM-52 beta-lactamases in Escherichia coli strains from healthy pets in Portugal. J Antimicrob Chemother 2004; 54: 960-961.
12. Dolejska M, Duskova E, Rybarikova J, Janoszowska D, et al. Plasmids carrying blaCTX-M-1 and qnr genes in Escherichia coli isolates from an equine clinic and a horseback riding centre. J Antimicrob Chemother 2011; 66:757-764.
13. Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother 2006; 57:14-23.
14. EFSA. Panel on Biological Hazards (BIOHAZ); Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum beta-lactamases and/or AmpC betalactamases in food and food-producing animals. EFSA J 2011; 9:2322.
15. Ewers C, Grobbel M, Bethe A, Wieler LH, et al. Extendedspectrum beta-lactamases-producing gram-negative bacteria in companion animals: Action is clearly warranted! Berl Munch Tierarztl Wochenschr 2011; 124:94-101.
16. Gibson JS, Cobbold RN, Trott DJ. Characterization of multidrugresistant Escherichia coli isolated from extraintestinal clinical infections in animals. J Med Microbiol 2010; 59:592-598.
17. Guardabassi L, Schwarz S, Lloyd DH. Pet animals as reservoirs of antimicrobial-resistant bacteria. J Antimicrob Chemother 2004; 54:321-332.
18. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009; 22: 161-182.
19. Jacoby GA, Griffin CM, Hooper DC. Citrobacter spp. as a source of qnrB alleles. Antimicrob Agents Chemother 2011; 55: 4979-4984.
20. Jouini A, Vinue L, Ben Slama K, Saenz Y, et al. Characterization of CTX-M and SHV extended-spectrum beta-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother 2007; 60: 1137-1141.
21. Mataseje LF, Baudry PJ, Zhanel GG, Morck DW, et al. Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada. Diagn Microbiol Infect Dis 2010; 67:387-391.
22. Moreno A, Bello H, Guggiana D, Dom?nguez M, et al. Extended-spectrum b-lactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin. Vet Microbiol 2008; 129:203-208.
23. Murphy C, Reid-Smith RJ, Prescott JF, Bonnett BN, et al. Occurrence of antimicrobial resistant bacteria in healthy dogs and cats presented to private veterinary hospitals in southern Ontario: A preliminary study. Can Vet J 2009; 50: 1047-1053.
24. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: The worldwide emergence of clone ST131 O25:H4.Int J Antimicrob Agents 2010; 35:316-321.
25. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40:2153-2162.
26. Pitout JD. Infections with extended-spectrum beta-lactamaseproducing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010; 70: 313-333.
27. Pomba C, da Fonseca JD, Baptista BC, Correia JD, et al. Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6)-Ib-cr genes in a dog. Antimicrob Agents Chemother 2009; 53:327-328.
28. Ruiz J, Simon K, Horcajada JP, Velasco M, et al. Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol 2002; 40:4445-4449.
29. Saenz Y, Zarazaga M, Brin as L, Ruiz-Larrea F, et al. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals. J Antimicrob Chemother 2003; 51:1001-1005.
30. Saenz Y, Brin as L, Dom?nguez E, Ruiz J, et al. Mechanisms of resistance in multiple-antibiotic resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother 2004; 48:3996-4001.
31. Saenz Y, Vinue L, Ruiz E, Somalo S, et al. Class 1 integrons lacking qacEDelta1 and sul1 genes in Escherichia coli isolates of food, animal and human origins. Vet Microbiol 2010; 144: 493-497.
32. Sanchez S, McCrackin Stevenson MA, Hudson CR, Maier M, et al. Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. J Clin Microbiol 2002; 40:3586-3595.
33. Schink AK, Kadlec K, Schwarz S. Analysis of blaCTX-M-carrying plasmids from Escherichia coli Isolates collected in the BfT-GermVet Study. Appl Environ Microbiol 2011; 77:7142-7146.
34. Schink AK, Kadlec K, Schwarz S. Detection of qnr genes among Escherichia coli isolates of animal origin and complete sequence of the conjugative qnrB19-carrying plasmid pQNR2078.J Antimicrob Chemother 2012; 67:1099-1102.
35. Sun Y, Zeng Z, Chen S, Ma J, et al. High prevalence of blaCTX-M extended-spectrum b-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect 2010; 16:1475-1481.
36. SVARM. SVARM Swedish Veterinarian Antimicrobial Resistance Monitoring, 2009.ISSN 1650-6332, 2009.
37. Tan TY, Ng LS, He J, Koh TH, et al. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Antimicrob Agents Chemother 2009; 53:146-149.
38. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239.
39. Vinue L, Lantero M, Saenz Y, Somalo S, et al. Characterization of extended-spectrum beta-lactamases and integrons in Escherichia coli isolates in a Spanish hospital. J Med Microbiol 2008; 57:916-920.
40. Yan JJ, Hong CY, Ko WC, Chen YJ, Tsai SH, Chuang CL, Wu JJ. Dissemination of blaCMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan. Antimicrob Agents Chemother 2004; 48: 1353-1356.